25 May 2013
Keywords: regeneron, enters, phase, ii, study, pharmaceuticals, begun
Article | 25 January 1993
Regeneron Pharmaceuticals has begun a Phase II study in the USA of its
recombinant human ciliary neutrophic factor for the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 January 1993
18 January 1993
24 May 2013
© 2013 thepharmaletter.com